The first description of the flow-directed pulmonary artery catheter (PAC) was published in the 1970’s by Jeremy Swan and William Ganz. Ever since its clinical debut, many controversies surrounded the use of the PAC. Regardless of these controversies, the most fundamental issues surrounding this hemodynamic monitoring device remain unresolved, including the exact indications, contraindications, identification of patients who potentially benefit from this technology, and the way we interpret and use PAC-derived parameters. Despite recent intensification of attacks against the use of the PAC by its opponents, it seems overly harsh to discount a technology that might be beneficial in appropriately selected clinical situations, especially when considering the fact that our true knowledge of this technology is somewhat limited. In fact, the pulmonary artery catheter may still play an important role considering the resurgence of the concepts of euvolemic resuscitation and hemodynamic sufficiency.

Citation: Stawicki SP, Prosciak MP. The pulmonary artery catheter in 2008 – a (finally) maturing modality? OPUS 12 Scientist 2008;2(4):5-9.

Keywords: Pulmonary artery catheter, Hemodynamic monitoring, Euvolemic resuscitation, Hemodynamic sufficiency, Surgical critical care, Metabolic debris.

Copyright 2007-2008 OPUS 12 Foundation, Inc.